Share-based Payment Arrangement, Expense of PURE BIOSCIENCE, INC. from 31 Jan 2013 to 31 Oct 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
PURE BIOSCIENCE, INC. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Jan 2013 to 31 Oct 2025.
  • PURE BIOSCIENCE, INC. Share-based Payment Arrangement, Expense for the quarter ending 31 Oct 2025 was $34,000, a 40% decline year-over-year.
  • PURE BIOSCIENCE, INC. annual Share-based Payment Arrangement, Expense for 2025 was $144,000, a 33% decline from 2024.
  • PURE BIOSCIENCE, INC. annual Share-based Payment Arrangement, Expense for 2024 was $214,000, a 18% decline from 2023.
  • PURE BIOSCIENCE, INC. annual Share-based Payment Arrangement, Expense for 2023 was $262,000.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

PURE BIOSCIENCE, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $34,000 -$23,000 -40% 01 Aug 2025 31 Oct 2025 10-Q 15 Dec 2025 2026 Q1
Q3 2024 $57,000 -$23,000 -29% 01 Aug 2024 31 Oct 2024 10-Q 15 Dec 2025 2026 Q1
Q3 2023 $80,000 +$17,000 +27% 01 Aug 2023 31 Oct 2023 10-Q 16 Dec 2024 2025 Q1
Q3 2022 $63,000 -$106,000 -63% 01 Aug 2022 31 Oct 2022 10-Q 14 Dec 2023 2024 Q1
Q3 2021 $169,000 -$39,000 -19% 01 Aug 2021 31 Oct 2021 10-Q 14 Dec 2022 2023 Q1
Q3 2020 $208,000 -$60,000 -22% 01 Aug 2020 31 Oct 2020 10-Q 15 Dec 2021 2022 Q1
Q4 2019 $477,000 $68,000 -$176,000 -72% 01 Nov 2019 31 Jan 2020 10-Q 12 Mar 2020 2020 Q2
Q3 2019 $653,000 $268,000 -$734,000 -73% 01 Aug 2019 31 Oct 2019 10-Q 15 Dec 2020 2021 Q1
Q2 2019 $1,387,000 $58,000 01 May 2019 31 Jul 2019 10-K 08 Oct 2020 2020 FY
Q1 2019 $83,000 -$143,000 -63% 01 Feb 2019 30 Apr 2019 10-Q 13 Jun 2019 2019 Q3
Q4 2018 $244,000 -$212,000 -46% 01 Nov 2018 31 Jan 2019 10-Q 12 Mar 2020 2020 Q2
Q3 2018 $1,002,000 01 Aug 2018 31 Oct 2018 10-Q 13 Dec 2019 2020 Q1
Q1 2018 $226,000 01 Feb 2018 30 Apr 2018 10-Q 13 Jun 2019 2019 Q3
Q4 2017 $456,000 01 Nov 2017 31 Jan 2018 10-Q 06 Mar 2019 2019 Q2
Q2 2016 $1,902,000 $281,000 -$350,000 -55% 01 May 2016 31 Jul 2016 10-K 27 Oct 2016 2016 FY
Q1 2016 $2,252,000 $186,000 -$580,000 -76% 01 Feb 2016 30 Apr 2016 10-Q 09 Jun 2016 2016 Q3
Q4 2015 $2,832,000 $763,000 +$281,000 +58% 01 Nov 2015 31 Jan 2016 10-Q 09 Mar 2016 2016 Q2
Q3 2015 $2,551,000 $672,000 +$169,000 +34% 01 Aug 2015 31 Oct 2015 10-Q 10 Dec 2015 2016 Q1
Q2 2015 $2,382,000 $631,000 -$136,000 -18% 01 May 2015 31 Jul 2015 10-K 27 Oct 2016 2016 FY
Q1 2015 $2,518,000 $766,000 -$4,000 -0.52% 01 Feb 2015 30 Apr 2015 10-Q 09 Jun 2016 2016 Q3
Q4 2014 $2,522,000 $482,000 -$850,000 -64% 01 Nov 2014 31 Jan 2015 10-Q 09 Mar 2016 2016 Q2
Q3 2014 $3,372,000 $503,000 +$414,000 +465% 01 Aug 2014 31 Oct 2014 10-Q 10 Dec 2015 2016 Q1
Q2 2014 $2,958,000 $767,000 01 May 2014 31 Jul 2014 10-K 28 Oct 2015 2015 FY
Q1 2014 $770,000 +$617,000 +403% 01 Feb 2014 30 Apr 2014 10-Q 11 Jun 2015 2015 Q3
Q4 2013 $1,332,000 +$1,090,000 +450% 01 Nov 2013 31 Jan 2014 10-Q 04 Mar 2015 2015 Q2
Q3 2013 $89,000 01 Aug 2013 31 Oct 2013 10-Q 11 Dec 2014 2015 Q1
Q1 2013 $153,000 01 Feb 2013 30 Apr 2013 10-Q 10 Jun 2014 2014 Q3
Q4 2012 $242,000 01 Nov 2012 31 Jan 2013 10-Q 13 Mar 2014 2014 Q2

PURE BIOSCIENCE, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $144,000 -$70,000 -33% 01 Aug 2024 31 Jul 2025 10-K 29 Oct 2025 2025 FY
2024 $214,000 -$48,000 -18% 01 Aug 2023 31 Jul 2024 10-K 29 Oct 2025 2025 FY
2023 $262,000 01 Aug 2022 31 Jul 2023 10-K 29 Oct 2024 2024 FY
2021 $758,000 +$203,000 +37% 01 Aug 2020 31 Jul 2021 10-K 28 Oct 2021 2021 FY
2020 $555,000 -$832,000 -60% 01 Aug 2019 31 Jul 2020 10-K 08 Oct 2020 2020 FY
2019 $1,387,000 -$138,000 -9% 01 Aug 2018 31 Jul 2019 10-K 08 Oct 2020 2020 FY
2018 $1,525,000 01 Aug 2017 31 Jul 2018 10-K 30 Oct 2019 2019 FY
2016 $1,902,000 -$480,000 -20% 01 Aug 2015 31 Jul 2016 10-K 27 Oct 2016 2016 FY
2015 $2,382,000 -$576,000 -19% 01 Aug 2014 31 Jul 2015 10-K 27 Oct 2016 2016 FY
2014 $2,958,000 +$2,238,000 +311% 01 Aug 2013 31 Jul 2014 10-K 28 Oct 2015 2015 FY
2013 $720,000 01 Aug 2012 31 Jul 2013 10-K 28 Oct 2014 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.